FindTrial
Sign In

Investigation on compliance of lipid lowering drugs in community patients with dyslipidemia and Study on pharmaceutical intervention strategy

Investigation on the compliance of patients with dyslipidemia taking lipid-lowering drugs in community and study on pharmaceutical intervention strategies

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000037916
Enrollment
Unknown
Registered
2020-09-04
Start date
2020-09-05
Completion date
Unknown
Last updated
2021-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyslipidemia

Interventions

Case series:Questionnaire investigation

Sponsors

Gaobeidian Community Health Service Center, Chaoyang District, Beijing
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients over 18 years old have good orientation on time, place and characters; 2. Patients diagnosed as dyslipidemia are currently taking lipid-lowering drugs; 3. Patients with normal cognitive ability; 4. Patients who voluntarily participated in the study.

Exclusion criteria

Exclusion criteria: 1. Patients with mental disorders, such as schizophrenia, severe depression, etc.; 2. Patients with serious complications of heart, brain, lung and other organs or severe abnormal liver and kidney function.

Design outcomes

Primary

MeasureTime frame
Compliance;—

Secondary

MeasureTime frame
low density lipoprotein, LDL-C;—

Countries

China

Contacts

Public ContactLuo Lei

Gaobeidian Community Health Service Center, Chaoyang District, Beijing

1820594891@qq.com+86 15810851376

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026